Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients
ConditionRecurrent Ovarian Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorPower Life Sciences Inc.
About this trial
Clinical trials, with a particular focus on recurrent ovarian cancer, play a crucial role in assessing the safety and efficacy of novel treatments for this condition. These trials serve as essential tools to determine whether new medications outperform traditional therapies, providing substantial evidence to support their widespread adoption.
By actively participating in recurrent ovarian cancer observational study serves pivotal role in expanding the boundaries of medical knowledge and advancing the quality of care provided to those enduring the same condition.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Aged ≥ 18 years old
Able to comprehend the investigational nature of the protocol and provide informed consent
Diagnosis of recurrent ovarian cancer
Disqualifiers
No diagnosis of recurrent ovarian cancer confirmed
Inability to perform regular electronic reporting
Patient does not understand, sign, and return consent form
Trial population
Patients with recurrent ovarian cancer who are actively considering enrolling in a clinical trial for said condition, but have not yet completed enrollment and randomization.
Trial design
Design model
Case-crossover
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Number of patients who decide to participate in a recurrent ovarian cancer clinical trial
Time frame
3 months2
Rate of patients who remain in recurrent ovarian cancer clinical research to trial completion
Time frame
12 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: